American Journal of Kidney Diseases
Volume 51, Issue 4, Supplement 2 , Pages S21-S29 , April 2008

Diabetes Mellitus in CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition and Examination Survey (NHANES) 1999-2004

  • Adam T. Whaley-Connell, DO, MSPH

      Affiliations

    • University of Missouri-Columbia School of Medicine and Harry S Truman VA Medical Center, Columbia, MO
    • Corresponding Author InformationAddress correspondence to Adam T. Whaley-Connell, DO, MSPH, Assistant Professor of Medicine, University of Missouri-Columbia School of Medicine, Department of Internal Medicine, Division of Nephrology, MA436, DC043.0, One Hospital Dr, Columbia, MO 65212.
  • ,
  • James R. Sowers, MD

      Affiliations

    • University of Missouri-Columbia School of Medicine and Harry S Truman VA Medical Center, Columbia, MO
  • ,
  • Samy I. McFarlane, MD, MPH

      Affiliations

    • SUNY Downstate, Brooklyn, NY
  • ,
  • Keith C. Norris, MD

      Affiliations

    • Charles R. Drew University of Medicine and Science, Los Angeles, CA
    • David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA
  • ,
  • Shu-Cheng Chen, MS

      Affiliations

    • Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN
  • ,
  • Suying Li, PhD

      Affiliations

    • Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN
  • ,
  • Yang Qiu, MS

      Affiliations

    • Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN
  • ,
  • Changchun Wang, MS

      Affiliations

    • Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN
  • ,
  • Lesley A. Stevens, MD

      Affiliations

    • Tufts-New England Medical Center, Boston, MA
  • ,
  • Joseph A. Vassalotti, MD

      Affiliations

    • National Kidney Foundation, New York, NY
    • Department of Medicine, Division of Nephrology, Mount Sinai School of Medicine, New York, NY.
  • ,
  • Allan J. Collins, MD

      Affiliations

    • Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN
  • ,
  • Kidney Early Evaluation Program Investigators

Received 7 November 2007 ,Accepted 11 December 2007.

  • Image Result

    Prevalence of (A) self-reported diabetes mellitus by age and (B) self-reported risk factors observed in patients with diabetes mellitus. Data grouped by chronic kidney disease stages determined as fol

    Prevalence of (A) self-reported diabetes mellitus by age and (B) self-reported risk factors observed in patients with diabetes mellitus. Data grouped by chronic kidney disease stages determined as follows: stage 1, estimated glomerular filtration rate (eGFR) of 90 mL/min/1.73 m2 or greater and albumin-creatinine ratio (ACR) of 30 mg/g or greater; stage 2, eGFR of 60 to 89 mL/min/1.73 m2 and ACR of 30 mg/g or greater; stage 3, eGFR of 30 to 59 mL/min/1.73 m2; stage 4, eGFR of 15 to 29 mL/min/1.73 m2; and stage 5, eGFR less than 15 mL/min/1.73 m2. To convert eGFR from mL/min/1.73 m2 to mL/s/1.73 m2, multiply by 0.01667.

  • Image Result
    Adjusted odds ratios by chronic kidney disease stage for self-reported nondiabetic Kidney Early Evaluation Program (KEEP) participants of having increased fasting blood glucose levels of 127 mg/dL or

    Adjusted odds ratios by chronic kidney disease stage for self-reported nondiabetic Kidney Early Evaluation Program (KEEP) participants of having increased fasting blood glucose levels of 127 mg/dL or greater or nonfasting levels of 140 mg/dL or greater. Chronic kidney disease stages determined as described in Fig 1. To convert blood glucose from mg/dL to mmol/L, multiply by 0.0555.

  • Image Result
    Adjusted odds ratios by chronic kidney disease stage for self-reported diabetic KEEP participants with target fasting blood glucose levels less than 127 mg/dL or nonfasting blood glucose levels less t

    Adjusted odds ratios by chronic kidney disease stage for self-reported diabetic KEEP participants with target fasting blood glucose levels less than 127 mg/dL or nonfasting blood glucose levels less than 140 mg/dL. Chronic kidney disease stages determined as described in Fig 1. To convert blood glucose from mg/dL to mmol/L, multiply by 0.0555.

 A list of the members of the Kidney Early Evaluation Program Investigators appears at the end of this article.

PII: S0272-6386(07)01665-4

doi: 10.1053/j.ajkd.2007.12.013

American Journal of Kidney Diseases
Volume 51, Issue 4, Supplement 2 , Pages S21-S29 , April 2008